Verastem | VSTM - Interest Expense On Debt


Verastem reported $382K in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
AstraZeneca USD 340M 144M Jun/2026
Curis USD 178K 441K Dec/2023
Cytokinetics USD 34.83M 1.5M Jun/2026
Gilead Sciences USD 247M 7M Jun/2026
Incyte USD 582K 13K Jun/2026
Laboratory Of America USD 59.1M 2M Sep/2026
Novartis USD 462M 119M Jun/2026
Pfizer USD 667M 4M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025
TG Therapeutics USD 16.57M 8.91M Jun/2026
Verastem USD 382K 33K Mar/2026